Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001144204-18-019363
Filing Date
2018-04-05
Accepted
2018-04-05 15:06:03
Documents
85
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A tv490179_10ka.htm 10-K/A 102690
  Complete submission text file 0001144204-18-019363.txt   6087452

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT xtnt-20171231.xml EX-101.INS 1434522
3 XBRL TAXONOMY EXTENSION SCHEMA xtnt-20171231.xsd EX-101.SCH 72661
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xtnt-20171231_cal.xml EX-101.CAL 79095
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xtnt-20171231_def.xml EX-101.DEF 453655
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE xtnt-20171231_lab.xml EX-101.LAB 520427
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xtnt-20171231_pre.xml EX-101.PRE 509987
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

EIN.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-34951 | Film No.: 18740306
SIC: 2836 Biological Products, (No Diagnostic Substances)